Safety of Ombitasvir/Paritaprevir/Ritonavir+dasabuvir in Chronic Hepatitis C Patients With HCV Genotype 1 Infection
Acta Poloniae Pharmaceutica - Poland
doi 10.32383/appdr/105681
Full Text
Open PDFAbstract
Available in full text
Date
August 30, 2019
Authors
Publisher
Polish Pharmaceutical Society